1. Home
  2. IMAB vs BRIA Comparison

IMAB vs BRIA Comparison

Compare IMAB & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • BRIA
  • Stock Information
  • Founded
  • IMAB 2014
  • BRIA 2011
  • Country
  • IMAB United States
  • BRIA Singapore
  • Employees
  • IMAB N/A
  • BRIA N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • BRIA
  • Sector
  • IMAB Health Care
  • BRIA
  • Exchange
  • IMAB Nasdaq
  • BRIA NYSE
  • Market Cap
  • IMAB 79.9M
  • BRIA 76.2M
  • IPO Year
  • IMAB 2020
  • BRIA 2024
  • Fundamental
  • Price
  • IMAB $0.97
  • BRIA $3.02
  • Analyst Decision
  • IMAB Strong Buy
  • BRIA
  • Analyst Count
  • IMAB 3
  • BRIA 0
  • Target Price
  • IMAB $8.00
  • BRIA N/A
  • AVG Volume (30 Days)
  • IMAB 270.1K
  • BRIA 15.2K
  • Earning Date
  • IMAB 03-13-2025
  • BRIA 03-04-2025
  • Dividend Yield
  • IMAB N/A
  • BRIA N/A
  • EPS Growth
  • IMAB N/A
  • BRIA N/A
  • EPS
  • IMAB N/A
  • BRIA 92.24
  • Revenue
  • IMAB $569,464.00
  • BRIA $55,755,669.00
  • Revenue This Year
  • IMAB N/A
  • BRIA N/A
  • Revenue Next Year
  • IMAB N/A
  • BRIA N/A
  • P/E Ratio
  • IMAB N/A
  • BRIA $0.03
  • Revenue Growth
  • IMAB N/A
  • BRIA 8.03
  • 52 Week Low
  • IMAB $0.84
  • BRIA $2.90
  • 52 Week High
  • IMAB $2.00
  • BRIA $4.38
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 46.51
  • BRIA N/A
  • Support Level
  • IMAB $0.96
  • BRIA N/A
  • Resistance Level
  • IMAB $1.04
  • BRIA N/A
  • Average True Range (ATR)
  • IMAB 0.05
  • BRIA 0.00
  • MACD
  • IMAB -0.00
  • BRIA 0.00
  • Stochastic Oscillator
  • IMAB 36.36
  • BRIA 0.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

Share on Social Networks: